# Bavarian Nordic awarded USD 63M US government contract for smallpox/mpox vaccines

Bavarian Nordic received a USD 63 million order from BARDA to manufacture bulk product and 1 million freeze-dried doses of JYNNEOS smallpox/mpox vaccine. Bulk production is planned for 2025, with freeze-dried doses delivered in 2026.

- Type: Contract
- Announced: 2024-09-24
- Where: United States
- Value: $63.0M
- Status: announced
- Capacity: 1 million freeze-dried doses
- Products: smallpox/mpox vaccine

## Companies

- [Bavarian Nordic](https://endata.com/companies/26366.md)
- [BARDA](https://endata.com/companies/8812.md) (customer)

## Sources

- [biospace.com](https://www.biospace.com/press-releases/bavarian-nordic-awarded-usd-63-million-from-the-u-s-government-for-production-and-supply-of-additional-smallpox-mpox-vaccines), 2024-09-25: "This award further strengthens the orders for the public preparedness business for 2025 and beyond and is yet another resounding endorsement of MVA-BN as the leading smallpox/mpox vaccine."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.